Emmanuel Scotet Selected Research

Emmanuel Scotet Research Topics

Disease

31	Neoplasms (Cancer) 04/2024 - 11/2002
5	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 10/2017
5	Infections 04/2014 - 10/2006
3	Melanoma (Melanoma, Malignant) 03/2021 - 01/2012
2	Inflammation (Inflammations) 04/2024 - 12/2009
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2024 - 02/2018
1	Sepsis (Septicemia) 04/2024
1	Glioma (Gliomas) 01/2020
1	Ovarian Epithelial Carcinoma 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Brucellosis (Malta Fever) 01/2012
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Reactive Arthritis (Reiter Disease) 02/2002

Drug/Important Bio-Agent (IBA)

6	LigandsIBA 03/2021 - 10/2005
3	AntibodiesIBA 10/2021 - 01/2017
2	Interleukin-2 (IL2)IBA 01/2024 - 03/2009
2	ButyrophilinsIBA 01/2021 - 01/2016
2	MART-1 AntigenIBA 01/2020 - 01/2012
2	AntigensIBA 01/2020 - 01/2012
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020 - 01/2005
2	interleukin-21 (interleukin 21)IBA 06/2018 - 03/2009
2	Mevalonic Acid (Mevalonate)IBA 01/2016 - 01/2014
1	ChemokinesIBA 04/2024
1	laminaranIBA 04/2024
1	Zoledronic Acid (Zometa)FDA Link 01/2024
1	B7-H1 AntigenIBA 03/2021
1	Therapeutic UsesIBA 03/2021
1	Immune Checkpoint InhibitorsIBA 03/2021
1	Diphosphonates (Bisphosphonates)IBA 01/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2018
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 02/2018
1	N 30IBA 02/2018
1	Glutamine (L-Glutamine)FDA Link 10/2017
1	Annexin A2 (Annexin II)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	GlycolipidsIBA 05/2015
1	diphosphoric acid (pyrophosphoric acid)IBA 04/2014
1	Interleukin-12 (IL 12)IBA 01/2012
1	EpitopesIBA 01/2012
1	HLA-B18 AntigenIBA 01/2012
1	Histocompatibility Antigens Class IIBA 03/2011
1	CalciumIBA 07/2010
1	Interleukin-17 (Interleukin 17)IBA 12/2009
1	Pathogen-Associated Molecular Pattern MoleculesIBA 09/2009
1	Terpenes (Terpenoids)IBA 03/2009
1	CytokinesIBA 10/2006
1	Proteins (Proteins, Gene)FDA Link 10/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2005
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 10/2005
1	isopentenyl pyrophosphate (isopentenyl diphosphate)IBA 10/2005
1	Proton-Translocating ATPases (ATPase, H+)IBA 01/2005
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2005
1	Indicators and Reagents (Reagents)IBA 11/2002
1	Bispecific AntibodiesIBA 11/2002
1	T-Cell Antigen Receptor-CD3 ComplexIBA 11/2002
1	HLA-B*27:05 antigenIBA 02/2002
1	Interleukin-10 (Interleukin 10)IBA 02/2002

Therapy/Procedure

15	Immunotherapy 01/2022 - 10/2005
7	Therapeutics 03/2021 - 01/2012
1	Drug Therapy (Chemotherapy) 01/2019
1	Transplantation 02/2018
1	Injections 01/2018